Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT06009874

Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI

Led by Mohammad Hussien Tantawy Soliman · Updated on 2023-08-24

80

Participants Needed

1

Research Sites

147 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to investigate the effect of early administration of DAPA during ischemia and before pPCI on infarct size, reperfusion injury-related myocardial damage, cardioprotection from HF, and renoprotection from AKI in patients with AMI.

CONDITIONS

Official Title

Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with ST-elevation myocardial infarction (STEMI)
  • STEMI defined by the Fourth Universal Definition of AMI
  • Age between 18 and 80 years
  • Both diabetics and non-diabetics allowed
  • Estimated glomerular filtration rate (eGFR) greater than 45 ml/min/1.73m2
  • Blood pressure above 110/70 mmHg before first dose
Not Eligible

You will not qualify if you...

  • Presence of cardiogenic shock
  • Experiencing hypoglycemia
  • History of diabetic ketoacidosis
  • Active genital or urinary infections
  • Previous history of acute myocardial infarction
  • Stent thrombosis
  • Prior coronary artery bypass surgery
  • Severe liver failure
  • Advanced cancer diagnosis
  • Blood pH less than 7.32
  • Known allergy to SGLT-2 inhibitors
  • Hemodynamic instability
  • Females of childbearing potential without adequate contraception
  • Current or prior use of any SGLT-2 inhibitors

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mohammad Soliman

Shibīn al Kawm, Menofia, Egypt, 32741

Actively Recruiting

Loading map...

Research Team

M

Mohammad Soliman

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here